Ali Moazzam

522 citations

39 papers · 370 indexed · h-index 13

Co-authors: Bagher Larijani Mohammad Mahdavi Aida Iraji Mohammad Ali Faramarzi Farnaz Jafarpour Somayeh Mojtabavi Maryam Mohammadi‐Khanaposhtani Abbas Rahmati
Topics: Natural Antidiabetic Agents Studies (9 papers)Synthesis and Characterization of Heterocyclic Compounds (7 papers)melanin and skin pigmentation (7 papers)
Cited by: Organic Chemistry Biochemistry Toxicology
Journals: Scientific Reports Tetrahedron Tetrahedron Letters
Partner nations: Iran Türkiye Austria

In The Last Decade

Ali Moazzam

38 papers receiving 363 citations

Peers

Countries citing papers authored by Ali Moazzam

Since Specialization

Citations

This map shows the geographic impact of Ali Moazzam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Moazzam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Moazzam more than expected).

Fields of papers citing papers by Ali Moazzam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Moazzam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Moazzam. The network helps show where Ali Moazzam may publish in the future.

Co-authorship network of co-authors of Ali Moazzam

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Moazzam. A scholar is included among the top collaborators of Ali Moazzam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Moazzam. Ali Moazzam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure–activity relationship studies 2024 ·Scientific Reports ·Haleh Hamedifar,(unknown),(unknown),Homa Azizian,Aida Iraji,Milad Noori,Ali Moazzam,Navid Dastyafteh,(unknown),(unknown),Shahrzad Javanshir,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Bagher Larijani,(unknown),Mohammad Mahdavi	7
2	Phenyldiazenyl-phenoxy-1,2,3-triazol-acetamide derivatives as new dual cholinesterase Inhibitors: Design, synthesis, in vitro, and in silico enzymatic inhibition evaluations 2024 ·Journal of Molecular Structure ·Samira Zareei,Maryam Mohammadi‐Khanaposhtani,(unknown),Halil Şenol,(unknown),Ali Moazzam,Shahrzad Mohseni,Ensieh Nasli‐Esfahani,(unknown),Bagher Larijani,(unknown),Essam H. Ibrahim,Hamed A. Ghramh,Parham Taslımı	10
3	Structure-based Drug Design of New Cinnamic Acid Derivatives asTyrosinase Inhibitors 2024 ·Letters in Organic Chemistry ·(unknown),Mohammad Hosein Sayahi,Ali Moazzam,Fatemeh Gholami,Nader Tanideh,Cambyz Irajie,(unknown),(unknown),Bagher Larijani,Maliheh Barazandeh Tehrani,Mohammad Mahdavi,Aida Iraji	1
4	Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents 2024 ·Scientific Reports ·Mohammad Hosein Sayahi,Samira Zareei,(unknown),(unknown),Ali Moazzam,Maryam Mohammadi‐Khanaposhtani,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Hossein Rastegar,Parham Taslımı,Essam H. Ibrahim,Hamed A. Ghramh,Bagher Larijani,Mohammad Mahdavi	7
5	Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors 2023 ·Heliyon ·(unknown),Mohammad Hosein Sayahi,Somayeh Behrouz,Ali Moazzam,(unknown),Nader Tanideh,Cambyz Irajie,(unknown),Bagher Larijani,Aida Iraji,Mohammad Mahdavi	10
6	Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase 2023 ·Scientific Reports ·(unknown),(unknown),Mohammad Hosein Sayahi,(unknown),Ali Moazzam,Maryam Mohammadi‐Khanaposhtani,Somayeh Mojtabavi,Mehdi Asadi,Mohammad Ali Faramarzi,Bagher Larijani,Massoud Amanlou,Mohammad Mahdavi	12
7	Eco-friendly, green and new metal-free intramolecular Friedel–Crafts reaction to synthesis of Acridones derivatives using phenylboronic acid derivatives 2023 ·Tetrahedron Letters ·(unknown),Ali Moazzam,Mohammad Hosein Sayahi,(unknown),Mehdi Adib,Mohammad Mahdavi	2
8	Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents 2023 ·Scientific Reports ·(unknown),(unknown),Nader Tanideh,Ali Moazzam,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Cambyz Irajie,(unknown),(unknown),Bagher Larijani,(unknown),Aida Iraji,Mohammad Mahdavi	13
9	Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides 2023 ·Heliyon ·Keyvan Pedrood,(unknown),Ali Moazzam,Aida Iraji,(unknown),Samira Ansari,Sayed Mahmoud Sajjadi‐Jazi,Mohammad Reza Mohajeri‐Tehrani,(unknown),Vahid Haghpanah,(unknown),Bagher Larijani,Haleh Hamedifar,Neda Adibpour,Mohammad Mahdavi	12
10	Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies 2023 ·Bioorganic Chemistry ·Samira Zareei,Sara Ranjbar,Mohammad Hossein Mohammadi,Younes Ghasemi,(unknown),(unknown),Ali Moazzam,Bagher Larijani,Maryam Mohammadi‐Khanaposhtani,(unknown),Mohammad Mahdavi,Nastaran Sadeghian,Parham Taslımı	5
11	Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents 2023 ·Scientific Reports ·(unknown),(unknown),Ali Moazzam,Samanesadat Hosseini,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Reza Ghadimi,Ali Akbar Moghadamnia,Ensieh Nasli‐Esfahani,Maryam Mohammadi‐Khanaposhtani,Mohammad Mahdavi	6
12	Design, synthesis docking and molecular dynamics studies of 2-amino-4-phenylthiazole-indole hybrids as α-glucosidase inhibitors 2023 ·Journal of Molecular Structure ·(unknown),(unknown),Mohammad Hosein Sayahi,(unknown),Ali Moazzam,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Hossein Rastegar,Maryam Mohammadi‐Khanaposhtani,Mohammad Mahdavi	2
13	Copper Catalyst-Supported Modified Magnetic Chitosan for the Synthesis of Novel 2-Arylthio-2,3-dihydroquinazolin-4(1H)-one Derivatives via Chan–Lam Coupling 2022 ·Inorganics ·(unknown),(unknown),Saeed Bahadorikhalili,Ali Moazzam,(unknown),Bagher Larijani,Aida Iraji,Shahram Moradi,Mohammad Mahdavi	8
14	A Facile and Efficient One-Pot Procedure for the Synthesis of Novel 2-Substituted 3-Thioxoisoindolin-1-one Derivatives 2022 ·Synlett ·Mehdi Adib,Mohammad Mahdavi,Fatemeh Gholami,Ali Moazzam,Saeed Bahadorikhalili,Samanesadat Hosseini,Bagher Larijani	2
15	Evaluating the effects of disubstituted 3-hydroxy-1H-pyrrol-2(5H)-one analog as novel tyrosinase inhibitors 2022 ·Bioorganic Chemistry ·(unknown),Mohammad Hosein Sayahi,Aida Iraji,(unknown),Ali Moazzam,(unknown),Mehdi Adib,(unknown),Bagher Larijani,Hossein Rastegar,Mehdi Khoshneviszadeh,Mohammad Mahdavi	21
16	Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives 2022 ·Scientific Reports ·Homa Azizian,Keyvan Pedrood,Ali Moazzam,(unknown),(unknown),(unknown),Maryam Mohammadi‐Khanaposhtani,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Samanesadat Hosseini,Yaghoub Sarrafi,Hossein Adibi,Bagher Larijani,Hossein Rastegar,Mohammad Mahdavi	29
17	Synthesis, molecular docking, and cytotoxicity of quinazolinone and dihydroquinazolinone derivatives as cytotoxic agents 2022 ·BMC Chemistry ·(unknown),Aida Iraji,Ali Moazzam,Meysam Soleimani,Mehdi Asadi,Keyvan Pedrood,(unknown),(unknown),Bagher Larijani,Neda Adibpour,Mohammad Mahdavi	7
18	Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents 2022 ·BMC Chemistry ·(unknown),Mohammad Hosein Sayahi,Somayeh Behrouz,Ali Moazzam,Somayeh Mojtabavi,Mohammad Ali Faramarzi,Bagher Larijani,Hossein Rastegar,Maryam Mohammadi‐Khanaposhtani,Mohammad Mahdavi	17
19	Backbone distortions in lactam‐bridged helical peptides 2022 ·Journal of Peptide Science ·Ali Moazzam,(unknown),(unknown),(unknown),(unknown),Andreas Zierer,Markus Wiederstein,Mario Schubert,Chiara Cabrele	3
20	A Conformationally Stable Acyclic β‐Hairpin Scaffold Tolerating the Incorporation of Poorly β‐Sheet‐Prone Amino Acids 2021 ·ChemBioChem ·(unknown),(unknown),Ali Moazzam,(unknown),(unknown),Łukasz Berlicki,Mario Schubert,Chiara Cabrele	9

About Ali Moazzam

Ali Moazzam is a scholar working on Organic Chemistry, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 39 papers that have together received 370 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (9 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and melanin and skin pigmentation (7 papers). The work is most often cited by research in Organic Chemistry (247 citations), Biochemistry (20 citations) and Toxicology (10 citations). Ali Moazzam has collaborated with scholars based in Iran, Türkiye and Austria. Frequent co-authors include Bagher Larijani, Mohammad Mahdavi, Aida Iraji, Mohammad Ali Faramarzi, Farnaz Jafarpour, Somayeh Mojtabavi, Maryam Mohammadi‐Khanaposhtani, Abbas Rahmati, Samanesadat Hosseini and Mohammad Hosein Sayahi. Their work appears in journals such as Scientific Reports, Tetrahedron and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact